Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 6.48% |
| FEDERAL MOGU | FDML | 6.24% |
| NEW ORIENTAL | EDU | 6.17% |
| NATUS MEDICA | BABY | 5.20% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We have maintained our Outperform recommendation on Findlay, Ohio-based independent oil refiner and marketer Marathon Petroleum Corporation ( MPC - Analyst Report ) .
The company, in its current form, came into existence following the 2011 spin-off of Houston, Texas-based Marathon Oil Corporation’s ( MRO - Analyst Report ) refining/sales business into a separate, independent and publicly traded entity. Marathon Petroleum operates in three segments: Refining and Marketing, Speedway (Retail) and Pipeline Transportation.
It is the fifth largest domestic refiner with a combined crude oil processing capacity of approximately 1,193,000 barrels per day through its portfolio of six refineries. A major advantage for the company is its proprietary access to pipelines, which inhibits lower-cost competitors from supplying Marathon Petroleum's key markets.
Our bullish investment theme stems from Marathon Petroleum’s scale advantage, impressive asset quality, and an extensive midstream/retail network that diversifies its portfolio and provides more stable revenue streams.
The company’s financial flexibility and strong balance sheet are also real assets in this highly uncertain economic period. Marathon Petroleum remains in excellent financial health, with nearly $2 billion in cash/cash equivalents and an investment-grade credit rating with a debt-to-capitalization ratio of 24%. Furthermore, an attractive dividend yield and the $2 billion share buyback program – that commenced recently – highlight the company’s commitment to create value for shareholders.
Marathon Petroleum is almost through with its $2.2 billion Detroit Heavy Oil Upgrading Project. Ongoing since 2008, the initiative – on budget and on schedule – is expected to finish later this year. The completion of the project will not only deliver an extra 80,000 barrels a day of heavy oil processing capacity but also free up capital expenditures and boost the company’s free cash flow.
Marathon Petroleum is looking at strategic alternatives for some of its pipeline assets, including the possible formation of a master limited partnership by way of an initial public offering. We believe this potential spin-off could further enhance the company’s shareholder worth and valuation.
These factors, coupled with the relatively inexpensive valuation, make Marathon Petroleum an attractive investment.
Read the full Analyst Report on MPC
Read the full Analyst Report on MRO